Skip to main content

McKesson Corporation North American Pharmaceutical revenue

  • MCK · NYSE
  • Distribution
  • Health Care Distributors
  • S&P 500
$1102.80+2.39%Close 13 Nov 2026 · Market value $127.9B

North American Pharmaceutical revenue at McKesson Corporation came to $91.4B for the quarter to 30 Sep 2026, up 5.6% from a year earlier.

As McKesson Corporation reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$80.0BSep 2024$81.2BDec 2024$82.7BJun 2025$86.5BSep 2025$88.3BDec 2025$79.1BMar 2026$86.8BJun 2026$91.4BSep 2026
McKesson Corporation North American Pharmaceutical revenue, every reported period
Period endingNorth American Pharmaceutical revenueChange on a yearFiled
30 Sep 2026$91.4Bup 5.6%4 Nov 2026
30 Jun 2026$86.8Bup 4.9%5 Aug 2026
31 Mar 2026$79.1B—8 May 2026
31 Dec 2025$88.3Bup 8.8%4 Feb 2026
30 Sep 2025$86.5Bup 8.1%6 Nov 2025
30 Jun 2025$82.7B—6 Aug 2025
31 Dec 2024$81.2B—6 Feb 2025
30 Sep 2024$80.0B—7 Nov 2024

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of McKesson Corporation: Oncology & Multispecialty revenue · Medical-Surgical Solutions revenue · Prescription Technology Solutions revenue · financial statements

Every KPI and segment of MCK, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.